# C_2023239EN.01005801.xml

| 6.7.2023 | EN | Official Journal of the European Union | C 239/58 |
| --- | --- | --- | --- |

6.7.2023

EN

Official Journal of the European Union

C 239/58

---

Medicinal products – List of marketing authorisations granted by the EEA EFTA States for the second half of 2022

(2023/C 239/04)

Subcommittee I on the free movement of goods

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No.74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 July – 31 December 2022, at the meeting on 17 March 2023:

| Annex I | List of new marketing authorisations |
| --- | --- |

Annex I

| Annex II | List of renewed marketing authorisations |
| --- | --- |

Annex II

| Annex III | List of extended marketing authorisations |
| --- | --- |

Annex III

| Annex IV | List of withdrawn marketing authorisations |
| --- | --- |

Annex IV

| Annex V | List of suspended marketing authorisations |
| --- | --- |

Annex V

---

ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 July – 31 December 2022:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/21/1579 | Nexviadyme | Iceland | 13.7.2022 |
| EU/1/21/1579 | Nexviadyme | Norway | 4.7.2022 |
| EU/1/21/1580 | VidPrevtyn Beta | Iceland | 7.12.2022 |
| EU/1/21/1580 | VidPrevtyn Beta | Liechtenstein | 30.11.2022 |
| EU/1/21/1580 | VidPrevtyn Beta | Norway | 11.11.2022 |
| EU/1/21/1587 | Rayvow | Iceland | 31.8.2022 |
| EU/1/21/1587 | Rayvow | Liechtenstein | 31.8.2022 |
| EU/1/21/1587 | Rayvow | Norway | 6.9.2022 |
| EU/1/22/1629 | ZOLSKETIL pegylated liposomal | Norway | 11.8.2022 |
| EU/1/22/1646 | Amifampridine SERB | Iceland | 12.8.2022 |
| EU/1/22/1650 | Tabrecta | Iceland | 12.7.2022 |
| EU/1/22/1650 | Tabrecta | Norway | 5.7.2022 |
| EU/1/22/1652 | Filsuvez | Iceland | 12.8.2022 |
| EU/1/22/1652 | Filsuvez | Norway | 1.8.2022 |
| EU/1/22/1653 | Upstaza | Iceland | 12.8.2022 |
| EU/1/22/1653 | Upstaza | Liechtenstein | 31.7.2022 |
| EU/1/22/1653 | Upstaza | Norway | 25.7.2022 |
| EU/1/22/1655 | Pirfenidone AET | Iceland | 12.7.2022 |
| EU/1/22/1655 | Pirfenidone axunio | Liechtenstein | 30.6.2022 |
| EU/1/22/1655 | Pirfenidone AET | Norway | 5.7.2022 |
| EU/1/22/1656 | Ertapenem SUN | Iceland | 11.8.2022 |
| EU/1/22/1656 | Ertapenem SUN | Liechtenstein | 31.7.2022 |
| EU/1/22/1656 | Ertapenem SUN | Norway | 10.8.2022 |
| EU/1/22/1657 | Kinpeygo | Iceland | 19.7.2022 |
| EU/1/22/1657 | Kinpeygo | Liechtenstein | 31.7.2022 |
| EU/1/22/1657 | Kinpeygo | Norway | 21.7.2022 |
| EU/1/22/1658 | Ganirelix Gedeon Richter | Iceland | 21.7.2022 |
| EU/1/22/1658 | Ganirelix Gedeon Richter | Liechtenstein | 31.7.2022 |
| EU/1/22/1658 | Ganirelix Gedeon Richter | Norway | 25.7.2022 |
| EU/1/22/1659 | Xenpozyme | Iceland | 13.7.2022 |
| EU/1/22/1659 | Xenpozyme | Norway | 4.7.2022 |
| EU/1/22/1660 | Zokinvy | Iceland | 21.7.2022 |
| EU/1/22/1660 | Zokinvy | Liechtenstein | 31.7.2022 |
| EU/1/22/1660 | Zokinvy | Norway | 21.7.2022 |
| EU/1/22/1661 | Sitagliptin/Metformin hydrochloride Accord | Iceland | 15.8.2022 |
| EU/1/22/1661 | Sitagliptin/Metformin Hydrochloride Accord | Liechtenstein | 31.7.2022 |
| EU/1/22/1661 | Sitagliptin Metformin Hydrochloride Accord | Norway | 1.8.2022 |
| EU/1/22/1662 | Pyrukynd | Iceland | 1.12.2022 |
| EU/1/22/1662 | Pyrukynd | Liechtenstein | 30.11.2022 |
| EU/1/22/1662 | Pyrukynd | Norway | 30.11.2022 |
| EU/1/22/1663 | Sugammadex Fresenius Kabi | Iceland | 19.7.2022 |
| EU/1/22/1663 | Sugammadex Fresenius Kabi | Liechtenstein | 31.7.2022 |
| EU/1/22/1663 | Sugammadex Fresenius Kabi | Norway | 25.7.2022 |
| EU/1/22/1664 | Cevenfacta | Iceland | 12.8.2022 |
| EU/1/22/1664 | Cevenfacta | Liechtenstein | 31.7.2022 |
| EU/1/22/1664 | Cevenfacta | Norway | 22.8.2022 |
| EU/1/22/1666 | Celdoxome pegylated liposomal | Liechtenstein | 30.9.2022 |
| EU/1/22/1666 | Celdoxome pegylated liposomal | Norway | 10.10.2022 |
| EU/1/22/1667 | Celdoxome pegylated liposomal | Iceland | 11.10.2022 |
| EU/1/22/1667 | Vegzelma | Iceland | 23.8.2022 |
| EU/1/22/1667 | Vegzelma | Liechtenstein | 31.8.2022 |
| EU/1/22/1667 | Vegzelma | Norway | 30.8.2022 |
| EU/1/22/1668 | Roctavian | Iceland | 31.8.2022 |
| EU/1/22/1668 | Roctavian | Liechtenstein | 31.8.2022 |
| EU/1/22/1668 | Roctavian | Norway | 30.8.2022 |
| EU/1/22/1669 | Pepaxti | Iceland | 23.8.2022 |
| EU/1/22/1669 | Pepaxti | Liechtenstein | 31.8.2022 |
| EU/1/22/1669 | Pepaxti | Norway | 30.8.2022 |
| EU/1/22/1670 | Scemblix | Iceland | 30.8.2022 |
| EU/1/22/1670 | Scemblix | Liechtenstein | 31.8.2022 |
| EU/1/22/1670 | Scemblix | Norway | 30.8.2022 |
| EU/1/22/1671 | Sunlenca | Iceland | 23.8.2022 |
| EU/1/22/1671 | Sunlenca | Liechtenstein | 31.8.2022 |
| EU/1/22/1671 | Sunlenca | Norway | 30.8.2022 |
| EU/1/22/1672 | Livtencity | Iceland | 1.12.2022 |
| EU/1/22/1672 | Livtencity | Liechtenstein | 30.11.2022 |
| EU/1/22/1672 | Livtencity | Norway | 9.11.2022 |
| EU/1/22/1673 | Ranivisio | Iceland | 30.8.2022 |
| EU/1/22/1673 | Ranivisio | Liechtenstein | 31.8.2022 |
| EU/1/22/1673 | Ranivisio | Norway | 30.8.2022 |
| EU/1/22/1674 | Vyvgart | Iceland | 17.8.2022 |
| EU/1/22/1674 | Vyvgart | Liechtenstein | 31.8.2022 |
| EU/1/22/1674 | Vyvgart | Norway | 15.8.2022 |
| EU/1/22/1675 | Tecvayli | Iceland | 7.9.2022 |
| EU/1/22/1675 | Tecvayli | Liechtenstein | 31.8.2022 |
| EU/1/22/1675 | Tecvayli | Norway | 30.8.2022 |
| EU/1/22/1676 | Thalidomide Lipomed | Iceland | 12.10.2022 |
| EU/1/22/1676 | Thalidomide Lipomed | Liechtenstein | 30.9.2022 |
| EU/1/22/1676 | Thalidomide Lipomed | Norway | 5.10.2022 |
| EU/1/22/1677 | Tezspire | Iceland | 12.10.2022 |
| EU/1/22/1677 | Tezspire | Liechtenstein | 30.9.2022 |
| EU/1/22/1677 | Tezspire | Norway | 26.9.2022 |
| EU/1/22/1678 | Lupkynis | Iceland | 12.10.2022 |
| EU/1/22/1678 | Lupkynis | Liechtenstein | 30.9.2022 |
| EU/1/22/1678 | Lupkynis | Norway | 20.9.2022 |
| EU/1/22/1679 | Opdualag | Iceland | 11.10.2022 |
| EU/1/22/1679 | Opdualag | Liechtenstein | 30.9.2022 |
| EU/1/22/1679 | Opdualag | Norway | 20.9.2022 |
| EU/1/22/1680 | ilLuzyce | Iceland | 10.10.2022 |
| EU/1/22/1680 | ilLuzyce | Liechtenstein | 30.9.2022 |
| EU/1/22/1680 | ilLuzyce | Norway | 20.9.2022 |
| EU/1/22/1681 | Amvuttra | Iceland | 10.10.2022 |
| EU/1/22/1681 | Amvuttra | Liechtenstein | 30.9.2022 |
| EU/1/22/1681 | Amvuttra | Norway | 20.9.2022 |
| EU/1/22/1683 | Vabysmo | Iceland | 11.10.2022 |
| EU/1/22/1683 | Vabysmo | Liechtenstein | 30.9.2022 |
| EU/1/22/1683 | Vabysmo | Norway | 26.9.2022 |
| EU/1/22/1684 | Nulibry | Liechtenstein | 30.9.2022 |
| EU/1/22/1684 | Nulibry | Norway | 26.9.2022 |
| EU/1/22/1685 | Mounjaro | Iceland | 11.10.2022 |
| EU/1/22/1685 | Mounjaro | Liechtenstein | 30.9.2022 |
| EU/1/22/1685 | Mounjaro | Norway | 28.10.2022 |
| EU/1/22/1687 | Enjaymo | Iceland | 8.12.2022 |
| EU/1/22/1687 | Enjaymo | Liechtenstein | 30.11.2022 |
| EU/1/22/1688 | Spevigo | Liechtenstein | 31.12.2022 |
| EU/1/22/1688 | Spevigo | Norway | 21.12.2022 |
| EU/1/22/1689 | Beyfortus | Iceland | 18.11.2022 |
| EU/1/22/1689 | Beyfortus | Liechtenstein | 31.10.2022 |
| EU/1/22/1689 | Beyfortus | Norway | 23.11.2022 |
| EU/1/22/1690 | Mycapssa | Iceland | 14.12.2022 |
| EU/1/22/1690 | Mycapssa | Liechtenstein | 31.12.2022 |
| EU/1/22/1690 | Mycapssa | Norway | 2.12.2022 |
| EU/1/22/1691 | Ximluci | Iceland | 1.12.2022 |
| EU/1/22/1691 | Ximluci | Liechtenstein | 30.11.2022 |
| EU/1/22/1691 | Ximluci | Norway | 30.11.2022 |
| EU/1/22/1692 | Locametz | Liechtenstein | 31.12.2022 |
| EU/1/22/1693 | Teriflunomide Accord | Iceland | 8.12.2022 |
| EU/1/22/1693 | Teriflunomide Accord | Liechtenstein | 30.11.2022 |
| EU/1/22/1693 | Teriflunomide Accord | Norway | 30.11.2022 |
| EU/1/22/1694 | Melatonin Neurim | Iceland | 7.12.2022 |
| EU/1/22/1694 | Melatonin Neurim | Liechtenstein | 30.11.2022 |
| EU/1/22/1694 | Melatonin Neurim | Norway | 1.12.2022 |
| EU/1/22/1695 | Zynlonta | Liechtenstein | 31.12.2022 |
| EU/1/22/1696 | Sorafenib Accord | Iceland | 8.12.2022 |
| EU/1/22/1696 | Sorafenib Accord | Liechtenstein | 30.11.2022 |
| EU/1/22/1696 | Sorafenib Accord | Norway | 30.11.2022 |
| EU/1/22/1697 | Teriparatide Sun | Iceland | 1.12.2022 |
| EU/1/22/1697 | Teriparatide Sun | Liechtenstein | 30.11.2022 |
| EU/1/22/1697 | Teriparatide Sun | Norway | 1.12.2022 |
| EU/1/22/1698 | Teriflunomide Mylan | Iceland | 8.12.2022 |
| EU/1/22/1698 | Teriflunomide Mylan | Liechtenstein | 30.11.2022 |
| EU/1/22/1698 | Teruflunamide Mylan | Norway | 1.12.2022 |
| EU/1/22/1699 | Qdenga | Iceland | 15.12.2022 |
| EU/1/22/1699 | Qdenga | Liechtenstein | 31.12.2022 |
| EU/1/22/1699 | Qdenga | Norway | 14.12.2022 |
| EU/1/22/1700 | Ebvallo | Liechtenstein | 31.12.2022 |
| EU/1/22/1700 | Ebvallo | Norway | 21.12.2022 |
| EU/1/22/1701 | Plerixafor Accord | Liechtenstein | 31.12.2022 |
| EU/1/22/1701 | Plerixafor Accord | Norway | 22.12.2022 |
| EU/1/22/1702 | Dimethyl Fumarate Teva | Liechtenstein | 31.12.2022 |
| EU/1/22/1703 | Pluvicto | Liechtenstein | 31.12.2022 |
| EU/1/22/1703 | Pluvicto | Norway | 15.12.2022 |
| EU/1/22/1704 | Livmarli | Liechtenstein | 31.12.2022 |
| EU/1/22/1704 | Livmarli | Norway | 15.12.2022 |
| EU/1/22/1705 | Pemetrexed Baxter | Iceland | 20.12.2022 |
| EU/1/22/1705 | Pemetrexed Baxter | Liechtenstein | 31.12.2022 |
| EU/1/22/1705 | Pemetrexed Baxter | Norway | 21.12.2022 |
| EU/1/22/1706 | Eladynos | Liechtenstein | 31.12.2022 |
| EU/1/22/1706 | Eladynos | Norway | 21.12.2022 |
| EU/1/22/1687 | Enjaymo | Norway | 1.12.2022 |
| EU/1/22/1687 | Enjaymo | Liechtenstein | 30.11.2022 |
| EU/1/22/1656 | Ertapenem Sun | Norway | 10.8.2022 |
| EU/1/22/1656 | Ertapenem Sun | Liechtenstein | 31.7.2022 |
| EU/2/21/281 | CircoMax | Iceland | 12.8.2022 |
| EU/2/22/284 | Evanovo | Iceland | 16.8.2022 |
| EU/2/22/284 | Evanovo | Liechtenstein | 31.7.2022 |
| EU/2/22/284 | Evanovo | Norway | 24.8.2022 |
| EU/2/22/286 | Coxatab | Iceland | 31.8.2022 |
| EU/2/22/286 | Coxatab | Liechtenstein | 31.8.2022 |
| EU/2/22/286 | Coxatab | Norway | 1.9.2022 |
| EU/2/22/287 | Cortaderm | Iceland | 17.8.2022 |
| EU/2/22/287 | Cortaderm | Liechtenstein | 31.7.2022 |
| EU/2/22/287 | Cortaderm | Norway | 24.8.2022 |
| EU/2/22/288 | Lotilaner Elanco | Iceland | 13.10.2022 |
| EU/2/22/288 | Lotilaner Elanco | Liechtenstein | 30.9.2022 |
| EU/2/22/288 | Lotilaner Elanco | Norway | 11.10.2022 |

EU-Number

Product

Country

Date of authorisation

EU/1/21/1579

Nexviadyme

Iceland

13.7.2022

EU/1/21/1579

Nexviadyme

Norway

4.7.2022

EU/1/21/1580

VidPrevtyn Beta

Iceland

7.12.2022

EU/1/21/1580

VidPrevtyn Beta

Liechtenstein

30.11.2022

EU/1/21/1580

VidPrevtyn Beta

Norway

11.11.2022

EU/1/21/1587

Rayvow

Iceland

31.8.2022

EU/1/21/1587

Rayvow

Liechtenstein

31.8.2022

EU/1/21/1587

Rayvow

Norway

6.9.2022

EU/1/22/1629

ZOLSKETIL pegylated liposomal

Norway

11.8.2022

EU/1/22/1646

Amifampridine SERB

Iceland

12.8.2022

EU/1/22/1650

Tabrecta

Iceland

12.7.2022

EU/1/22/1650

Tabrecta

Norway

5.7.2022

EU/1/22/1652

Filsuvez

Iceland

12.8.2022

EU/1/22/1652

Filsuvez

Norway

1.8.2022

EU/1/22/1653

Upstaza

Iceland

12.8.2022

EU/1/22/1653

Upstaza

Liechtenstein

31.7.2022

EU/1/22/1653

Upstaza

Norway

25.7.2022

EU/1/22/1655

Pirfenidone AET

Iceland

12.7.2022

EU/1/22/1655

Pirfenidone axunio

Liechtenstein

30.6.2022

EU/1/22/1655

Pirfenidone AET

Norway

5.7.2022

EU/1/22/1656

Ertapenem SUN

Iceland

11.8.2022

EU/1/22/1656

Ertapenem SUN

Liechtenstein

31.7.2022

EU/1/22/1656

Ertapenem SUN

Norway

10.8.2022

EU/1/22/1657

Kinpeygo

Iceland

19.7.2022

EU/1/22/1657

Kinpeygo

Liechtenstein

31.7.2022

EU/1/22/1657

Kinpeygo

Norway

21.7.2022

EU/1/22/1658

Ganirelix Gedeon Richter

Iceland

21.7.2022

EU/1/22/1658

Ganirelix Gedeon Richter

Liechtenstein

31.7.2022

EU/1/22/1658

Ganirelix Gedeon Richter

Norway

25.7.2022

EU/1/22/1659

Xenpozyme

Iceland

13.7.2022

EU/1/22/1659

Xenpozyme

Norway

4.7.2022

EU/1/22/1660

Zokinvy

Iceland

21.7.2022

EU/1/22/1660

Zokinvy

Liechtenstein

31.7.2022

EU/1/22/1660

Zokinvy

Norway

21.7.2022

EU/1/22/1661

Sitagliptin/Metformin hydrochloride Accord

Iceland

15.8.2022

EU/1/22/1661

Sitagliptin/Metformin Hydrochloride Accord

Liechtenstein

31.7.2022

EU/1/22/1661

Sitagliptin Metformin Hydrochloride Accord

Norway

1.8.2022

EU/1/22/1662

Pyrukynd

Iceland

1.12.2022

EU/1/22/1662

Pyrukynd

Liechtenstein

30.11.2022

EU/1/22/1662

Pyrukynd

Norway

30.11.2022

EU/1/22/1663

Sugammadex Fresenius Kabi

Iceland

19.7.2022

EU/1/22/1663

Sugammadex Fresenius Kabi

Liechtenstein

31.7.2022

EU/1/22/1663

Sugammadex Fresenius Kabi

Norway

25.7.2022

EU/1/22/1664

Cevenfacta

Iceland

12.8.2022

EU/1/22/1664

Cevenfacta

Liechtenstein

31.7.2022

EU/1/22/1664

Cevenfacta

Norway

22.8.2022

EU/1/22/1666

Celdoxome pegylated liposomal

Liechtenstein

30.9.2022

EU/1/22/1666

Celdoxome pegylated liposomal

Norway

10.10.2022

EU/1/22/1667

Celdoxome pegylated liposomal

Iceland

11.10.2022

EU/1/22/1667

Vegzelma

Iceland

23.8.2022

EU/1/22/1667

Vegzelma

Liechtenstein

31.8.2022

EU/1/22/1667

Vegzelma

Norway

30.8.2022

EU/1/22/1668

Roctavian

Iceland

31.8.2022

EU/1/22/1668

Roctavian

Liechtenstein

31.8.2022

EU/1/22/1668

Roctavian

Norway

30.8.2022

EU/1/22/1669

Pepaxti

Iceland

23.8.2022

EU/1/22/1669

Pepaxti

Liechtenstein

31.8.2022

EU/1/22/1669

Pepaxti

Norway

30.8.2022

EU/1/22/1670

Scemblix

Iceland

30.8.2022

EU/1/22/1670

Scemblix

Liechtenstein

31.8.2022

EU/1/22/1670

Scemblix

Norway

30.8.2022

EU/1/22/1671

Sunlenca

Iceland

23.8.2022

EU/1/22/1671

Sunlenca

Liechtenstein

31.8.2022

EU/1/22/1671

Sunlenca

Norway

30.8.2022

EU/1/22/1672

Livtencity

Iceland

1.12.2022

EU/1/22/1672

Livtencity

Liechtenstein

30.11.2022

EU/1/22/1672

Livtencity

Norway

9.11.2022

EU/1/22/1673

Ranivisio

Iceland

30.8.2022

EU/1/22/1673

Ranivisio

Liechtenstein

31.8.2022

EU/1/22/1673

Ranivisio

Norway

30.8.2022

EU/1/22/1674

Vyvgart

Iceland

17.8.2022

EU/1/22/1674

Vyvgart

Liechtenstein

31.8.2022

EU/1/22/1674

Vyvgart

Norway

15.8.2022

EU/1/22/1675

Tecvayli

Iceland

7.9.2022

EU/1/22/1675

Tecvayli

Liechtenstein

31.8.2022

EU/1/22/1675

Tecvayli

Norway

30.8.2022

EU/1/22/1676

Thalidomide Lipomed

Iceland

12.10.2022

EU/1/22/1676

Thalidomide Lipomed

Liechtenstein

30.9.2022

EU/1/22/1676

Thalidomide Lipomed

Norway

5.10.2022

EU/1/22/1677

Tezspire

Iceland

12.10.2022

EU/1/22/1677

Tezspire

Liechtenstein

30.9.2022

EU/1/22/1677

Tezspire

Norway

26.9.2022

EU/1/22/1678

Lupkynis

Iceland

12.10.2022

EU/1/22/1678

Lupkynis

Liechtenstein

30.9.2022

EU/1/22/1678

Lupkynis

Norway

20.9.2022

EU/1/22/1679

Opdualag

Iceland

11.10.2022

EU/1/22/1679

Opdualag

Liechtenstein

30.9.2022

EU/1/22/1679

Opdualag

Norway

20.9.2022

EU/1/22/1680

ilLuzyce

Iceland

10.10.2022

EU/1/22/1680

ilLuzyce

Liechtenstein

30.9.2022

EU/1/22/1680

ilLuzyce

Norway

20.9.2022

EU/1/22/1681

Amvuttra

Iceland

10.10.2022

EU/1/22/1681

Amvuttra

Liechtenstein

30.9.2022

EU/1/22/1681

Amvuttra

Norway

20.9.2022

EU/1/22/1683

Vabysmo

Iceland

11.10.2022

EU/1/22/1683

Vabysmo

Liechtenstein

30.9.2022

EU/1/22/1683

Vabysmo

Norway

26.9.2022

EU/1/22/1684

Nulibry

Liechtenstein

30.9.2022

EU/1/22/1684

Nulibry

Norway

26.9.2022

EU/1/22/1685

Mounjaro

Iceland

11.10.2022

EU/1/22/1685

Mounjaro

Liechtenstein

30.9.2022

EU/1/22/1685

Mounjaro

Norway

28.10.2022

EU/1/22/1687

Enjaymo

Iceland

8.12.2022

EU/1/22/1687

Enjaymo

Liechtenstein

30.11.2022

EU/1/22/1688

Spevigo

Liechtenstein

31.12.2022

EU/1/22/1688

Spevigo

Norway

21.12.2022

EU/1/22/1689

Beyfortus

Iceland

18.11.2022

EU/1/22/1689

Beyfortus

Liechtenstein

31.10.2022

EU/1/22/1689

Beyfortus

Norway

23.11.2022

EU/1/22/1690

Mycapssa

Iceland

14.12.2022

EU/1/22/1690

Mycapssa

Liechtenstein

31.12.2022

EU/1/22/1690

Mycapssa

Norway

2.12.2022

EU/1/22/1691

Ximluci

Iceland

1.12.2022

EU/1/22/1691

Ximluci

Liechtenstein

30.11.2022

EU/1/22/1691

Ximluci

Norway

30.11.2022

EU/1/22/1692

Locametz

Liechtenstein

31.12.2022

EU/1/22/1693

Teriflunomide Accord

Iceland

8.12.2022

EU/1/22/1693

Teriflunomide Accord

Liechtenstein

30.11.2022

EU/1/22/1693

Teriflunomide Accord

Norway

30.11.2022

EU/1/22/1694

Melatonin Neurim

Iceland

7.12.2022

EU/1/22/1694

Melatonin Neurim

Liechtenstein

30.11.2022

EU/1/22/1694

Melatonin Neurim

Norway

1.12.2022

EU/1/22/1695

Zynlonta

Liechtenstein

31.12.2022

EU/1/22/1696

Sorafenib Accord

Iceland

8.12.2022

EU/1/22/1696

Sorafenib Accord

Liechtenstein

30.11.2022

EU/1/22/1696

Sorafenib Accord

Norway

30.11.2022

EU/1/22/1697

Teriparatide Sun

Iceland

1.12.2022

EU/1/22/1697

Teriparatide Sun

Liechtenstein

30.11.2022

EU/1/22/1697

Teriparatide Sun

Norway

1.12.2022

EU/1/22/1698

Teriflunomide Mylan

Iceland

8.12.2022

EU/1/22/1698

Teriflunomide Mylan

Liechtenstein

30.11.2022

EU/1/22/1698

Teruflunamide Mylan

Norway

1.12.2022

EU/1/22/1699

Qdenga

Iceland

15.12.2022

EU/1/22/1699

Qdenga

Liechtenstein

31.12.2022

EU/1/22/1699

Qdenga

Norway

14.12.2022

EU/1/22/1700

Ebvallo

Liechtenstein

31.12.2022

EU/1/22/1700

Ebvallo

Norway

21.12.2022

EU/1/22/1701

Plerixafor Accord

Liechtenstein

31.12.2022

EU/1/22/1701

Plerixafor Accord

Norway

22.12.2022

EU/1/22/1702

Dimethyl Fumarate Teva

Liechtenstein

31.12.2022

EU/1/22/1703

Pluvicto

Liechtenstein

31.12.2022

EU/1/22/1703

Pluvicto

Norway

15.12.2022

EU/1/22/1704

Livmarli

Liechtenstein

31.12.2022

EU/1/22/1704

Livmarli

Norway

15.12.2022

EU/1/22/1705

Pemetrexed Baxter

Iceland

20.12.2022

EU/1/22/1705

Pemetrexed Baxter

Liechtenstein

31.12.2022

EU/1/22/1705

Pemetrexed Baxter

Norway

21.12.2022

EU/1/22/1706

Eladynos

Liechtenstein

31.12.2022

EU/1/22/1706

Eladynos

Norway

21.12.2022

EU/1/22/1687

Enjaymo

Norway

1.12.2022

EU/1/22/1687

Enjaymo

Liechtenstein

30.11.2022

EU/1/22/1656

Ertapenem Sun

Norway

10.8.2022

EU/1/22/1656

Ertapenem Sun

Liechtenstein

31.7.2022

EU/2/21/281

CircoMax

Iceland

12.8.2022

EU/2/22/284

Evanovo

Iceland

16.8.2022

EU/2/22/284

Evanovo

Liechtenstein

31.7.2022

EU/2/22/284

Evanovo

Norway

24.8.2022

EU/2/22/286

Coxatab

Iceland

31.8.2022

EU/2/22/286

Coxatab

Liechtenstein

31.8.2022

EU/2/22/286

Coxatab

Norway

1.9.2022

EU/2/22/287

Cortaderm

Iceland

17.8.2022

EU/2/22/287

Cortaderm

Liechtenstein

31.7.2022

EU/2/22/287

Cortaderm

Norway

24.8.2022

EU/2/22/288

Lotilaner Elanco

Iceland

13.10.2022

EU/2/22/288

Lotilaner Elanco

Liechtenstein

30.9.2022

EU/2/22/288

Lotilaner Elanco

Norway

11.10.2022

---

ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 July – 31 December 2022:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/11/699 | Fampyra | Iceland | 8.9.2022 |
| EU/1/11/749 | Caprelsa | Iceland | 13.12.2022 |
| EU/1/11/749 | Caprelsa | Liechtenstein | 30.11.2022 |
| EU/1/11/749 | Caprelsa | Norway | 9.12.2022 |
| EU/1/12/782 | Kalydeco | Iceland | 8.9.2022 |
| EU/1/12/784 | Cuprymina | Norway | 5.7.2022 |
| EU/1/12/794 | Adcetris | Norway | 27.9.2022 |
| EU/1/12/794 | Adcetris | Liechtenstein | 31.5.2022 (1) |
| EU/1/12/803 | NexoBrid | Iceland | 23.8.2022 |
| EU/1/12/803 | NexoBrid | Liechtenstein | 31.8.2022 |
| EU/1/12/803 | NexoBrid | Norway | 30.8.2022 |
| EU/1/13/901 | Sirturo | Liechtenstein | 31.12.2022 |
| EU/1/13/902 | Translarna | Norway | 12.7.2022 |
| EU/1/16/1094 | Ninlaro | Iceland | 6.10.2022 |
| EU/1/16/1094 | Ninlaro | Liechtenstein | 30.9.2022 |
| EU/1/16/1094 | Ninlaro | Norway | 24.10.2022 |
| EU/1/16/1169 | Alecensa | Iceland | 11.8.2022 |
| EU/1/16/1169 | Alecensa | Liechtenstein | 31.7.2022 |
| EU/1/16/1169 | Alecensa | Norway | 17.8.2022 |
| EU/1/17/1192 | Brineura | Iceland | 15.7.2022 |
| EU/1/17/1192 | Brineura | Norway | 15.8.2022 |
| EU/1/17/1195 | Erelzi | Norway | 16.8.2022 |
| EU/1/17/1199 | Cuprior | Iceland | 30.8.2022 |
| EU/1/17/1199 | Cuprior | Liechtenstein | 31.8.2022 |
| EU/1/17/1199 | Cuprior | Norway | 30.8.2022 |
| EU/1/17/1211 | Entecavir Accord | Iceland | 14.7.2022 |
| EU/1/17/1211 | Entecavir Accord | Liechtenstein | 31.7.2022 |
| EU/1/17/1211 | Entecavir Accord | Norway | 8.7.2022 |
| EU/1/17/1213 | Maviret | Norway | 16.8.2022 |
| EU/1/17/1215 | Fotivda | Iceland | 11.8.2022 |
| EU/1/17/1215 | Fotivda | Liechtenstein | 31.7.2022 |
| EU/1/17/1215 | Fotivda | Norway | 17.8.2022 |
| EU/1/17/1217 | Nitisinone MDK | Iceland | 11.8.2022 |
| EU/1/17/1217 | Nitisinone MDK | Liechtenstein | 31.7.2022 |
| EU/1/17/1217 | Nitisinone MDK | Norway | 17.8.2022 |
| EU/1/17/1218 | Rydapt | Norway | 15.8.2022 |
| EU/1/17/1222 | Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan | Norway | 12.8.2022 |
| EU/1/17/1223 | Vosevi | Iceland | 22.8.2022 |
| EU/1/17/1224 | Xermelo | Iceland | 12.7.2022 |
| EU/1/17/1224 | Xermelo | Norway | 12.07.2022 |
| EU/1/17/1226 | Lutathera | Iceland | 14.7.2022 |
| EU/1/17/1226 | Lutathera | Liechtenstein | 31.7.2022 |
| EU/1/17/1226 | Lutathera | Norway | 21.7.2022 |
| EU/1/17/1227 | Entecavir Mylan | Iceland | 12.7.2022 |
| EU/1/17/1227 | Entecavir Mylan | Norway | 5.7.2022 |
| EU/1/17/1228 | Tookad | Iceland | 13.10.2022 |
| EU/1/17/1228 | Tookad | Liechtenstein | 30.9.2022 |
| EU/1/17/1228 | Tookad | Norway | 27.10.2022 |
| EU/1/17/1229 | Dupixent | Iceland | 8.9.2022 |
| EU/1/17/1229 | Dupixent | Liechtenstein | 30.9.2022 |
| EU/1/17/1229 | Dupixent | Norway | 6.9.2022 |
| EU/1/17/1230 | Lacosamide Accord | Iceland | 30.8.2022 |
| EU/1/17/1230 | Lacosamide Accord | Liechtenstein | 31.8.2022 |
| EU/1/17/1230 | Lacosamide Accord | Norway | 24.8.2022 |
| EU/1/17/1231 | Ocrevus | Iceland | 12.10.2022 |
| EU/1/17/1231 | Ocrevus | Liechtenstein | 30.9.2022 |
| EU/1/17/1231 | Ocrevus | Norway | 27.9.2022 |
| EU/1/17/1232 | Miglustat Gen.Orph | Iceland | 12.10.2022 |
| EU/1/17/1232 | Miglustat Gen.Orph | Liechtenstein | 30.9.2022 |
| EU/1/17/1232 | Miglustat Gen.Orph. | Norway | 6.10.2022 |
| EU/1/17/1233 | Zubsolv | Iceland | 12.8.2022 |
| EU/1/17/1233 | Zubsolv | Liechtenstein | 31.7.2022 |
| EU/1/17/1233 | Zubsolv | Norway | 25.8.2022 |
| EU/1/17/1234 | Tremfya | Iceland | 21.7.2022 |
| EU/1/17/1234 | Tremfya | Liechtenstein | 31.7.2022 |
| EU/1/17/1234 | Tremfya | Norway | 21.7.2022 |
| EU/1/17/1235 | Zejula | Iceland | 11.8.2022 |
| EU/1/17/1235 | Zejula | Liechtenstein | 31.7.2022 |
| EU/1/17/1235 | Zejula | Norway | 15.8.2022 |
| EU/1/17/1236 | Trelegy Ellipta | Iceland | 19.7.2022 |
| EU/1/17/1236 | Trelegy Ellipta | Liechtenstein | 31.7.2022 |
| EU/1/17/1237 | Elebrato Ellipta | Iceland | 19.7.2022 |
| EU/1/17/1237 | Elebrato Ellipta | Liechtenstein | 31.7.2022 |
| EU/1/17/1237 | Elebrato Ellipta | Norway | 21.07.2022 |
| EU/1/17/1238 | Nyxoid | Iceland | 7.10.2022 |
| EU/1/17/1238 | Nyxoid | Liechtenstein | 30.9.2022 |
| EU/1/17/1238 | Nyxoid | Norway | 20.9.2022 |
| EU/1/17/1239 | VeraSeal | Iceland | 13.10.2022 |
| EU/1/17/1239 | VeraSeal | Liechtenstein | 30.9.2022 |
| EU/1/17/1239 | VeraSeal | Norway | 25.10.2022 |
| EU/1/17/1241 | Ontruzant | Iceland | 17.8.2022 |
| EU/1/17/1241 | Ontruzant | Liechtenstein | 31.7.2022 |
| EU/1/17/1241 | Ontruzant | Norway | 18.8.2022 |
| EU/1/17/1242 | Ritonavir Mylan | Iceland | 25.8.2022 |
| EU/1/17/1242 | Ritonavir Mylan | Liechtenstein | 31.8.2022 |
| EU/1/17/1242 | Ritonavir Mylan | Norway | 30.8.2022 |
| EU/1/17/1244 | Tacforius | Iceland | 15.8.2022 |
| EU/1/17/1244 | Tacforius | Liechtenstein | 31.8.2022 |
| EU/1/17/1244 | Tacforius | Norway | 25.8.2022 |
| EU/1/17/1245 | Prevymis | Liechtenstein | 31.8.2022 |
| EU/1/17/1245 | Prevymis | Norway | 13.9.2022 |
| EU/1/17/1246 | Mvasi | Iceland | 18.10.2022 |
| EU/1/17/1246 | Mvasi | Liechtenstein | 30.9.2022 |
| EU/1/17/1246 | Mvasi | Norway | 13.10.2022 |
| EU/1/17/1247 | Adynovi | Liechtenstein | 30.11.2022 |
| EU/1/17/1247 | Adynovi | Norway | 6.12.2022 |
| EU/1/17/1249 | Darunavir Krka | Liechtenstein | 30.11.2022 |
| EU/1/17/1249 | Darunavir Krka | Norway | 8.12.2022 |
| EU/1/17/1251 | Ozempic | Iceland | 12.10.2022 |
| EU/1/17/1251 | Ozempic | Liechtenstein | 30.9.2022 |
| EU/1/17/1251 | Ozempic | Norway | 27.9.2022 |
| EU/1/17/1252 | Fasenra | Iceland | 7.10.2022 |
| EU/1/17/1252 | Fasenra | Liechtenstein | 30.9.2022 |
| EU/1/17/1252 | Fasenra | Norway | 26.9.2022 |
| EU/1/17/1254 | Jorveza | Iceland | 13.10.2022 |
| EU/1/17/1254 | Jorveza | Liechtenstein | 30.9.2022 |
| EU/1/17/1254 | Joveza | Norway | 27.9.2022 |
| EU/1/17/1255 | Intrarosa | Iceland | 10.10.2022 |
| EU/1/17/1255 | Intrarosa | Liechtenstein | 30.9.2022 |
| EU/1/17/1255 | Intrarosa | Norway | 20.9.2022 |
| EU/1/17/1256 | Anagrelide Mylan | Iceland | 12.12.2022 |
| EU/1/17/1256 | Anagrelide Mylan | Liechtenstein | 30.11.2022 |
| EU/1/17/1256 | Anagrelide Mylan | Norway | 8.12.2022 |
| EU/1/17/1257 | Herzuma | Liechtenstein | 31.12.2022 |
| EU/1/17/1257 | Herzuma | Norway | 9.12.2022 |
| EU/1/17/1260 | Alkindi | Iceland | 5.12.2022 |
| EU/1/17/1260 | Alkindi | Liechtenstein | 30.11.2022 |
| EU/1/17/1260 | Alkindi | Norway | 6.12.2022 |
| EU/1/17/1263 | Efavirenz/Emtricitabine/Tenofovir disoproxil Krka | Iceland | 5.12.2022 |
| EU/1/17/1263 | Efavirenz/Emtricitabine/Tenofovir disoproxil Krka | Liechtenstein | 30.11.2022 |
| EU/1/17/1263 | Efavirenz/Emtricitabine/Tenofovir disoproxil Krka | Norway | 6.12.2022 |
| EU/1/18/1265 | Segluromet | Iceland | 5.12.2022 |
| EU/1/18/1265 | Segluromet | Liechtenstein | 30.11.2022 |
| EU/1/18/1265 | Segluromet | Norway | 6.12.2022 |
| EU/1/18/1266 | Steglujan | Iceland | 14.12.2022 |
| EU/1/18/1266 | Steglujan | Liechtenstein | 31.12.2022 |
| EU/1/18/1266 | Steglujan | Norway | 5.12.2022 |
| EU/1/18/1267 | Steglatro | Iceland | 8.12.2022 |
| EU/1/18/1267 | Steglatro | Liechtenstein | 30.11.2022 |
| EU/1/18/1267 | Steglatro | Norway | 23.11.2022 |
| EU/1/18/1271 | Hemlibra | Iceland | 7.10.2022 |
| EU/1/18/1271 | Hemlibra | Liechtenstein | 30.9.2022 |
| EU/1/18/1271 | Hemlibra | Norway | 20.9.2022 |
| EU/1/18/1272 | Shingrix | Iceland | 14.12.2022 |
| EU/1/18/1272 | Shingrix | Liechtenstein | 31.12.2022 |
| EU/1/18/1272 | Shingrix | Norway | 5.12.2022 |
| EU/1/18/1274 | Trydonis | Liechtenstein | 31.12.2022 |
| EU/1/18/1275 | Riarify | Liechtenstein | 31.12.2022 |
| EU/1/18/1275 | Riarify | Norway | 9.12.2022 |
| EU/1/18/1277 | Mylotarg | Iceland | 8.12.2022 |
| EU/1/18/1277 | Mylotarg | Liechtenstein | 30.11.2022 |
| EU/1/18/1277 | Mylotarg | Norway | 8.12.2022 |
| EU/1/18/1280 | Zessly | Iceland | 14.12.2022 |
| EU/1/18/1280 | Zessly | Liechtenstein | 30.11.2022 |
| EU/1/18/1280 | Zessly | Norway | 28.11.2022 |
| EU/1/19/1355 | Lorviqua | Norway | 16.8.2022 |
| EU/1/19/1376 | Libtayo | Iceland | 14.7.2022 |
| EU/1/19/1376 | Libtayo | Norway | 28.7.2022 |
| EU/1/19/1376 | Libtayo | Liechtenstein | 31.7.2022 |
| EU/1/19/1385 | Vitrakvi | Iceland | 31.8.2022 |
| EU/1/19/1385 | Vitrakvi | Liechtenstein | 31.8.2022 |
| EU/1/19/1385 | Vitrakvi | Norway | 12.9.2022 |
| EU/1/20/1437 | Dovprela | Iceland | 12.7.2022 |
| EU/1/20/1437 | Dovprela | Norway | 2.8.2022 |
| EU/1/20/1446 | Hepcludex | Iceland | 18.8.2022 |
| EU/1/20/1446 | Hepcludex | Norway | 16.8.2022 |
| EU/1/20/1459 | Veklury | Iceland | 17.8.2022 |
| EU/1/20/1459 | Veklury | Norway | 15.8.2022 |
| EU/1/20/1460 | Rozlytrek | Iceland | 1.9.2022 |
| EU/1/20/1460 | Rozlytrek | Norway | 16.8.2022 |
| EU/1/20/1471 | Idefirix | Iceland | 21.7.2022 |
| EU/1/20/1471 | Idefirix | Liechtenstein | 31.7.2022 |
| EU/1/20/1471 | Idefirix | Norway | 3.11.2022 |
| EU/1/20/1473 | Ayvakyt | Iceland | 30.8.2022 |
| EU/1/20/1473 | Ayvakyt | Liechtenstein | 31.7.2022 |
| EU/1/20/1473 | Ayvakyt | Norway | 2.8.2022 |
| EU/1/20/1474 | Blenrep | Iceland | 13.7.2022 |
| EU/1/20/1474 | Blenrep | Norway | 28.7.2022 |
| EU/1/20/1476 | Adakveo | Liechtenstein | 31.8.2022 |
| EU/1/20/1476 | Adakveo | Norway | 10.10.2022 |
| EU/1/20/1492 | Tecartus | Iceland | 8.12.2022 |
| EU/1/20/1492 | Tecartus | Liechtenstein | 30.11.2022 |
| EU/1/20/1507 | Spikevax | Iceland | 13.10.2022 |
| EU/1/20/1507 | Spikevax | Norway | 10.10.2022 |
| EU/1/20/1507 | Spikevax | Liechtenstein | 31.10.2022 |
| EU/1/20/1508 | Enhertu | Liechtenstein | 31.10.2022 |
| EU/1/20/1508 | Enhertu | Norway | 7.12.2022 |
| EU/1/20/1527 | Retsevmo | Liechtenstein | 31.12.2022 |
| EU/1/20/1528 | Comirnaty | Norway | 13.10.2022 |
| EU/1/20/1528 | Comirnaty | Iceland | 9.11.2022 |
| EU/1/20/1528 | Comirnaty | Liechtenstein | 31.10.2022 |
| EU/1/21/1529 | Vaxzevria | Norway | 4.11.2022 |
| EU/1/21/1529 | Vaxzevria | Liechtenstein | 31.10.2022 |
| EU/1/21/1537 | NEXPOVIO | Iceland | 25.8.2022 |
| EU/1/21/1539 | Abecma | Iceland | 12.7.2022 |
| EU/1/21/1539 | Abecma | Norway | 27.9.2022 |
| EU/1/21/1552 | Koselugo | Iceland | 8.9.2022 |
| EU/1/21/1555 | Gavreto | Iceland | 7.10.2022 |
| EU/1/21/1555 | Gavreto | Liechtenstein | 30.9.2022 |
| EU/1/21/1555 | Gavreto | Norway | 26.9.2022 |
| EU/1/21/1570 | Minjuvi | Iceland | 15.7.2022 |
| EU/1/21/1570 | Minjuvi | Liechtenstein | 31.7.2022 |
| EU/1/21/1570 | Minjuvi | Norway | 3.8.2022 |
| EU/1/21/1594 | Rybrevant | Iceland | 13.10.2022 |
| EU/1/21/1594 | Rybrevant | Liechtenstein | 30.9.2022 |
| EU/1/21/1594 | Rybrevant | Norway | 24.10.2022 |
| EU/1/21/1603 | Lumykras | Liechtenstein | 30.11.2022 |
| EU/1/21/1618 | Nuvaxovid | Liechtenstein | 31.10.2022 |
| EU/1/21/1618 | Nuvaxovid | Norway | 11.10.2022 |
| EU/1/22/1625 | Paxlovid | Iceland | 12.12.2022 |
| EU/1/22/1625 | Paxlovid | Liechtenstein | 30.11.2022 |
| EU/1/22/1625 | Paxlovid | Norway | 9.12.2022 |
| EU/2/12/143 | Nobivac L4 | Iceland | 16.9.2022 |
| EU/2/12/143 | Nobivac L4 | Liechtenstein | 31.7.2022 |
| EU/2/12/143 | Nobivac L4 | Norway | 18.8.2022 |
| EU/2/16/197 | Clynav | Liechtenstein | 30.6.2022 |
| EU/2/16/197 | Clynav | Norway | 16.8.2022 |
| EU/2/17/205 | CYTOPOINT | Iceland | 6.10.2022 |
| EU/2/17/206 | Credelio | Iceland | 6.10.2022 |
| EU/2/17/207 | Zulvac BTV | Iceland | 6.10.2022 |
| EU/2/17/209 | RESPIPORC FLUpan H1N1 | Iceland | 6.10.2022 |
| EU/2/17/210 | Zeleris | Iceland | 15.9.2022 |
| EU/2/17/211 | Prevomax | Iceland | 16.9.2022 |
| EU/2/17/211 | Prevomax | Liechtenstein | 31.7.2022 |
| EU/2/17/211 | Prevomax | Norway | 18.8.2022 |
| EU/2/17/212 | Exzolt | Iceland | 16.9.2022 |
| EU/2/17/212 | Exzolt | Liechtenstein | 31.7.2022 |
| EU/2/17/212 | Exzolt | Norway | 29.9.2022 |
| EU/2/17/214 | Vepured | Liechtenstein | 31.7.2022 |
| EU/2/17/214 | Vepured | Norway | 25.8.2022 |
| EU/2/17/215 | Suvaxyn PRRS MLV | Iceland | 16.9.2022 |
| EU/2/17/215 | Suvaxyn PRRS MLV | Liechtenstein | 31.7.2022 |
| EU/2/17/215 | Suvaxyn PRRS MLV | Norway | 18.8.2022 |
| EU/2/17/218 | Bovilis Blue-8 | Liechtenstein | 31.10.2022 |
| EU/2/17/218 | Bovilis Blue-8 | Norway | 25.10.2022 |
| EU/2/17/223 | Suvaxyn Circo | Norway | 22.7.2022 |
| EU/2/19/245 | Gumbohatch | Norway | 11.10.2022 |
| EU/2/20/269 | Solensia | Iceland | 16.9.2022 |
| EU/2/20/269 | Solensia | Norway | 7.9.2022 |
| EU/2/21/273 | Bonqat | Norway | 9.11.2022 |

EU-Number

Product

Country

Date of authorisation

EU/1/11/699

Fampyra

Iceland

8.9.2022

EU/1/11/749

Caprelsa

Iceland

13.12.2022

EU/1/11/749

Caprelsa

Liechtenstein

30.11.2022

EU/1/11/749

Caprelsa

Norway

9.12.2022

EU/1/12/782

Kalydeco

Iceland

8.9.2022

EU/1/12/784

Cuprymina

Norway

5.7.2022

EU/1/12/794

Adcetris

Norway

27.9.2022

EU/1/12/794

Adcetris

Liechtenstein

31.5.2022 (1)

EU/1/12/803

NexoBrid

Iceland

23.8.2022

EU/1/12/803

NexoBrid

Liechtenstein

31.8.2022

EU/1/12/803

NexoBrid

Norway

30.8.2022

EU/1/13/901

Sirturo

Liechtenstein

31.12.2022

EU/1/13/902

Translarna

Norway

12.7.2022

EU/1/16/1094

Ninlaro

Iceland

6.10.2022

EU/1/16/1094

Ninlaro

Liechtenstein

30.9.2022

EU/1/16/1094

Ninlaro

Norway

24.10.2022

EU/1/16/1169

Alecensa

Iceland

11.8.2022

EU/1/16/1169

Alecensa

Liechtenstein

31.7.2022

EU/1/16/1169

Alecensa

Norway

17.8.2022

EU/1/17/1192

Brineura

Iceland

15.7.2022

EU/1/17/1192

Brineura

Norway

15.8.2022

EU/1/17/1195

Erelzi

Norway

16.8.2022

EU/1/17/1199

Cuprior

Iceland

30.8.2022

EU/1/17/1199

Cuprior

Liechtenstein

31.8.2022

EU/1/17/1199

Cuprior

Norway

30.8.2022

EU/1/17/1211

Entecavir Accord

Iceland

14.7.2022

EU/1/17/1211

Entecavir Accord

Liechtenstein

31.7.2022

EU/1/17/1211

Entecavir Accord

Norway

8.7.2022

EU/1/17/1213

Maviret

Norway

16.8.2022

EU/1/17/1215

Fotivda

Iceland

11.8.2022

EU/1/17/1215

Fotivda

Liechtenstein

31.7.2022

EU/1/17/1215

Fotivda

Norway

17.8.2022

EU/1/17/1217

Nitisinone MDK

Iceland

11.8.2022

EU/1/17/1217

Nitisinone MDK

Liechtenstein

31.7.2022

EU/1/17/1217

Nitisinone MDK

Norway

17.8.2022

EU/1/17/1218

Rydapt

Norway

15.8.2022

EU/1/17/1222

Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan

Norway

12.8.2022

EU/1/17/1223

Vosevi

Iceland

22.8.2022

EU/1/17/1224

Xermelo

Iceland

12.7.2022

EU/1/17/1224

Xermelo

Norway

12.07.2022

EU/1/17/1226

Lutathera

Iceland

14.7.2022

EU/1/17/1226

Lutathera

Liechtenstein

31.7.2022

EU/1/17/1226

Lutathera

Norway

21.7.2022

EU/1/17/1227

Entecavir Mylan

Iceland

12.7.2022

EU/1/17/1227

Entecavir Mylan

Norway

5.7.2022

EU/1/17/1228

Tookad

Iceland

13.10.2022

EU/1/17/1228

Tookad

Liechtenstein

30.9.2022

EU/1/17/1228

Tookad

Norway

27.10.2022

EU/1/17/1229

Dupixent

Iceland

8.9.2022

EU/1/17/1229

Dupixent

Liechtenstein

30.9.2022

EU/1/17/1229

Dupixent

Norway

6.9.2022

EU/1/17/1230

Lacosamide Accord

Iceland

30.8.2022

EU/1/17/1230

Lacosamide Accord

Liechtenstein

31.8.2022

EU/1/17/1230

Lacosamide Accord

Norway

24.8.2022

EU/1/17/1231

Ocrevus

Iceland

12.10.2022

EU/1/17/1231

Ocrevus

Liechtenstein

30.9.2022

EU/1/17/1231

Ocrevus

Norway

27.9.2022

EU/1/17/1232

Miglustat Gen.Orph

Iceland

12.10.2022

EU/1/17/1232

Miglustat Gen.Orph

Liechtenstein

30.9.2022

EU/1/17/1232

Miglustat Gen.Orph.

Norway

6.10.2022

EU/1/17/1233

Zubsolv

Iceland

12.8.2022

EU/1/17/1233

Zubsolv

Liechtenstein

31.7.2022

EU/1/17/1233

Zubsolv

Norway

25.8.2022

EU/1/17/1234

Tremfya

Iceland

21.7.2022

EU/1/17/1234

Tremfya

Liechtenstein

31.7.2022

EU/1/17/1234

Tremfya

Norway

21.7.2022

EU/1/17/1235

Zejula

Iceland

11.8.2022

EU/1/17/1235

Zejula

Liechtenstein

31.7.2022

EU/1/17/1235

Zejula

Norway

15.8.2022

EU/1/17/1236

Trelegy Ellipta

Iceland

19.7.2022

EU/1/17/1236

Trelegy Ellipta

Liechtenstein

31.7.2022

EU/1/17/1237

Elebrato Ellipta

Iceland

19.7.2022

EU/1/17/1237

Elebrato Ellipta

Liechtenstein

31.7.2022

EU/1/17/1237

Elebrato Ellipta

Norway

21.07.2022

EU/1/17/1238

Nyxoid

Iceland

7.10.2022

EU/1/17/1238

Nyxoid

Liechtenstein

30.9.2022

EU/1/17/1238

Nyxoid

Norway

20.9.2022

EU/1/17/1239

VeraSeal

Iceland

13.10.2022

EU/1/17/1239

VeraSeal

Liechtenstein

30.9.2022

EU/1/17/1239

VeraSeal

Norway

25.10.2022

EU/1/17/1241

Ontruzant

Iceland

17.8.2022

EU/1/17/1241

Ontruzant

Liechtenstein

31.7.2022

EU/1/17/1241

Ontruzant

Norway

18.8.2022

EU/1/17/1242

Ritonavir Mylan

Iceland

25.8.2022

EU/1/17/1242

Ritonavir Mylan

Liechtenstein

31.8.2022

EU/1/17/1242

Ritonavir Mylan

Norway

30.8.2022

EU/1/17/1244

Tacforius

Iceland

15.8.2022

EU/1/17/1244

Tacforius

Liechtenstein

31.8.2022

EU/1/17/1244

Tacforius

Norway

25.8.2022

EU/1/17/1245

Prevymis

Liechtenstein

31.8.2022

EU/1/17/1245

Prevymis

Norway

13.9.2022

EU/1/17/1246

Mvasi

Iceland

18.10.2022

EU/1/17/1246

Mvasi

Liechtenstein

30.9.2022

EU/1/17/1246

Mvasi

Norway

13.10.2022

EU/1/17/1247

Adynovi

Liechtenstein

30.11.2022

EU/1/17/1247

Adynovi

Norway

6.12.2022

EU/1/17/1249

Darunavir Krka

Liechtenstein

30.11.2022

EU/1/17/1249

Darunavir Krka

Norway

8.12.2022

EU/1/17/1251

Ozempic

Iceland

12.10.2022

EU/1/17/1251

Ozempic

Liechtenstein

30.9.2022

EU/1/17/1251

Ozempic

Norway

27.9.2022

EU/1/17/1252

Fasenra

Iceland

7.10.2022

EU/1/17/1252

Fasenra

Liechtenstein

30.9.2022

EU/1/17/1252

Fasenra

Norway

26.9.2022

EU/1/17/1254

Jorveza

Iceland

13.10.2022

EU/1/17/1254

Jorveza

Liechtenstein

30.9.2022

EU/1/17/1254

Joveza

Norway

27.9.2022

EU/1/17/1255

Intrarosa

Iceland

10.10.2022

EU/1/17/1255

Intrarosa

Liechtenstein

30.9.2022

EU/1/17/1255

Intrarosa

Norway

20.9.2022

EU/1/17/1256

Anagrelide Mylan

Iceland

12.12.2022

EU/1/17/1256

Anagrelide Mylan

Liechtenstein

30.11.2022

EU/1/17/1256

Anagrelide Mylan

Norway

8.12.2022

EU/1/17/1257

Herzuma

Liechtenstein

31.12.2022

EU/1/17/1257

Herzuma

Norway

9.12.2022

EU/1/17/1260

Alkindi

Iceland

5.12.2022

EU/1/17/1260

Alkindi

Liechtenstein

30.11.2022

EU/1/17/1260

Alkindi

Norway

6.12.2022

EU/1/17/1263

Efavirenz/Emtricitabine/Tenofovir disoproxil Krka

Iceland

5.12.2022

EU/1/17/1263

Efavirenz/Emtricitabine/Tenofovir disoproxil Krka

Liechtenstein

30.11.2022

EU/1/17/1263

Efavirenz/Emtricitabine/Tenofovir disoproxil Krka

Norway

6.12.2022

EU/1/18/1265

Segluromet

Iceland

5.12.2022

EU/1/18/1265

Segluromet

Liechtenstein

30.11.2022

EU/1/18/1265

Segluromet

Norway

6.12.2022

EU/1/18/1266

Steglujan

Iceland

14.12.2022

EU/1/18/1266

Steglujan

Liechtenstein

31.12.2022

EU/1/18/1266

Steglujan

Norway

5.12.2022

EU/1/18/1267

Steglatro

Iceland

8.12.2022

EU/1/18/1267

Steglatro

Liechtenstein

30.11.2022

EU/1/18/1267

Steglatro

Norway

23.11.2022

EU/1/18/1271

Hemlibra

Iceland

7.10.2022

EU/1/18/1271

Hemlibra

Liechtenstein

30.9.2022

EU/1/18/1271

Hemlibra

Norway

20.9.2022

EU/1/18/1272

Shingrix

Iceland

14.12.2022

EU/1/18/1272

Shingrix

Liechtenstein

31.12.2022

EU/1/18/1272

Shingrix

Norway

5.12.2022

EU/1/18/1274

Trydonis

Liechtenstein

31.12.2022

EU/1/18/1275

Riarify

Liechtenstein

31.12.2022

EU/1/18/1275

Riarify

Norway

9.12.2022

EU/1/18/1277

Mylotarg

Iceland

8.12.2022

EU/1/18/1277

Mylotarg

Liechtenstein

30.11.2022

EU/1/18/1277

Mylotarg

Norway

8.12.2022

EU/1/18/1280

Zessly

Iceland

14.12.2022

EU/1/18/1280

Zessly

Liechtenstein

30.11.2022

EU/1/18/1280

Zessly

Norway

28.11.2022

EU/1/19/1355

Lorviqua

Norway

16.8.2022

EU/1/19/1376

Libtayo

Iceland

14.7.2022

EU/1/19/1376

Libtayo

Norway

28.7.2022

EU/1/19/1376

Libtayo

Liechtenstein

31.7.2022

EU/1/19/1385

Vitrakvi

Iceland

31.8.2022

EU/1/19/1385

Vitrakvi

Liechtenstein

31.8.2022

EU/1/19/1385

Vitrakvi

Norway

12.9.2022

EU/1/20/1437

Dovprela

Iceland

12.7.2022

EU/1/20/1437

Dovprela

Norway

2.8.2022

EU/1/20/1446

Hepcludex

Iceland

18.8.2022

EU/1/20/1446

Hepcludex

Norway

16.8.2022

EU/1/20/1459

Veklury

Iceland

17.8.2022

EU/1/20/1459

Veklury

Norway

15.8.2022

EU/1/20/1460

Rozlytrek

Iceland

1.9.2022

EU/1/20/1460

Rozlytrek

Norway

16.8.2022

EU/1/20/1471

Idefirix

Iceland

21.7.2022

EU/1/20/1471

Idefirix

Liechtenstein

31.7.2022

EU/1/20/1471

Idefirix

Norway

3.11.2022

EU/1/20/1473

Ayvakyt

Iceland

30.8.2022

EU/1/20/1473

Ayvakyt

Liechtenstein

31.7.2022

EU/1/20/1473

Ayvakyt

Norway

2.8.2022

EU/1/20/1474

Blenrep

Iceland

13.7.2022

EU/1/20/1474

Blenrep

Norway

28.7.2022

EU/1/20/1476

Adakveo

Liechtenstein

31.8.2022

EU/1/20/1476

Adakveo

Norway

10.10.2022

EU/1/20/1492

Tecartus

Iceland

8.12.2022

EU/1/20/1492

Tecartus

Liechtenstein

30.11.2022

EU/1/20/1507

Spikevax

Iceland

13.10.2022

EU/1/20/1507

Spikevax

Norway

10.10.2022

EU/1/20/1507

Spikevax

Liechtenstein

31.10.2022

EU/1/20/1508

Enhertu

Liechtenstein

31.10.2022

EU/1/20/1508

Enhertu

Norway

7.12.2022

EU/1/20/1527

Retsevmo

Liechtenstein

31.12.2022

EU/1/20/1528

Comirnaty

Norway

13.10.2022

EU/1/20/1528

Comirnaty

Iceland

9.11.2022

EU/1/20/1528

Comirnaty

Liechtenstein

31.10.2022

EU/1/21/1529

Vaxzevria

Norway

4.11.2022

EU/1/21/1529

Vaxzevria

Liechtenstein

31.10.2022

EU/1/21/1537

NEXPOVIO

Iceland

25.8.2022

EU/1/21/1539

Abecma

Iceland

12.7.2022

EU/1/21/1539

Abecma

Norway

27.9.2022

EU/1/21/1552

Koselugo

Iceland

8.9.2022

EU/1/21/1555

Gavreto

Iceland

7.10.2022

EU/1/21/1555

Gavreto

Liechtenstein

30.9.2022

EU/1/21/1555

Gavreto

Norway

26.9.2022

EU/1/21/1570

Minjuvi

Iceland

15.7.2022

EU/1/21/1570

Minjuvi

Liechtenstein

31.7.2022

EU/1/21/1570

Minjuvi

Norway

3.8.2022

EU/1/21/1594

Rybrevant

Iceland

13.10.2022

EU/1/21/1594

Rybrevant

Liechtenstein

30.9.2022

EU/1/21/1594

Rybrevant

Norway

24.10.2022

EU/1/21/1603

Lumykras

Liechtenstein

30.11.2022

EU/1/21/1618

Nuvaxovid

Liechtenstein

31.10.2022

EU/1/21/1618

Nuvaxovid

Norway

11.10.2022

EU/1/22/1625

Paxlovid

Iceland

12.12.2022

EU/1/22/1625

Paxlovid

Liechtenstein

30.11.2022

EU/1/22/1625

Paxlovid

Norway

9.12.2022

EU/2/12/143

Nobivac L4

Iceland

16.9.2022

EU/2/12/143

Nobivac L4

Liechtenstein

31.7.2022

EU/2/12/143

Nobivac L4

Norway

18.8.2022

EU/2/16/197

Clynav

Liechtenstein

30.6.2022

EU/2/16/197

Clynav

Norway

16.8.2022

EU/2/17/205

CYTOPOINT

Iceland

6.10.2022

EU/2/17/206

Credelio

Iceland

6.10.2022

EU/2/17/207

Zulvac BTV

Iceland

6.10.2022

EU/2/17/209

RESPIPORC FLUpan H1N1

Iceland

6.10.2022

EU/2/17/210

Zeleris

Iceland

15.9.2022

EU/2/17/211

Prevomax

Iceland

16.9.2022

EU/2/17/211

Prevomax

Liechtenstein

31.7.2022

EU/2/17/211

Prevomax

Norway

18.8.2022

EU/2/17/212

Exzolt

Iceland

16.9.2022

EU/2/17/212

Exzolt

Liechtenstein

31.7.2022

EU/2/17/212

Exzolt

Norway

29.9.2022

EU/2/17/214

Vepured

Liechtenstein

31.7.2022

EU/2/17/214

Vepured

Norway

25.8.2022

EU/2/17/215

Suvaxyn PRRS MLV

Iceland

16.9.2022

EU/2/17/215

Suvaxyn PRRS MLV

Liechtenstein

31.7.2022

EU/2/17/215

Suvaxyn PRRS MLV

Norway

18.8.2022

EU/2/17/218

Bovilis Blue-8

Liechtenstein

31.10.2022

EU/2/17/218

Bovilis Blue-8

Norway

25.10.2022

EU/2/17/223

Suvaxyn Circo

Norway

22.7.2022

EU/2/19/245

Gumbohatch

Norway

11.10.2022

EU/2/20/269

Solensia

Iceland

16.9.2022

EU/2/20/269

Solensia

Norway

7.9.2022

EU/2/21/273

Bonqat

Norway

9.11.2022

---

(1)  Authorisation was unintentionally omitted from the list for the 1st half of 2022.

---

ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 July – 31 December 2022:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/13/861/003-004 | Procysbi | Iceland | 23.8.2022 |
| EU/1/13/861/003-004 | Procysbi | Norway | 17.8.2022 |
| EU/1/15/1061 | Genvoya | Norway | 3.10.2022 |
| EU/1/15/1061/003-004 | Genvoya | Iceland | 13.10.2022 |
| EU/1/17/1217/004 | Nitisinone MDK | Norway | 16.8.2022 |
| EU/1/17/1229 | Dupixent | Norway | 13.10.2022 |
| EU/1/17/1229/021-022 | Dupixent | Norway | 16.8.2022 |
| EU/1/18/1289/005-006 | Biktavry | Norway | 9.12.2022 |
| EU/1/18/1289/005-006 | Biktavry | Iceland | 14.12.2022 |
| EU/1/19/1361/004-005 | Skyrizi | Norway | 8.12.2022 |
| EU/1/19/1404/010-011 | Rinvoq | Iceland | 16.8.2022 |
| EU/1/19/1404/010-011 | Rinvoq | Norway | 16.8.2022 |
| EU/1/20/1500/003 | Xofluza | Iceland | 6.9.2022 |
| EU/1/20/1507/002-003 | Spikevax | Norway | 16.8.2022 |
| EU/1/20/1507/004-005 | Spikevax bivalent Original/Omicron BA.1 | Norway | 01.09.2022 |
| EU/1/20/1507/002-003 | Spikevax | Iceland | 1.9.2022 |
| EU/1/20/1507/006 | Spikevax bivalent Original/Omicron BA.4-5 | Norway | 20.10.2022 |
| EU/1/20/1507/007-008 | Spikevax bivalent Original/Omicron BA.1 | Norway | 20.10.2022 |
| EU/1/20/1507/009-010 | Spikevax bivalent Original/Omicron BA.4-5 | Norway | 19.12.2022 |
| EU/1/20/1528/006 -007 | Comirnaty Original/Omicron BA.1 | Norway | 1.9.2022 |
| EU/1/20/1528/008 -009 | Comirnaty Original/Omicron BA. 4-5 | Norway | 12.9.2022 |
| EU/1/20/1528/010 | Comirnaty | Norway | 20.10.2022 |
| EU/1/20/1528/010 | Comirnaty | Iceland | 3.11.2022 |
| EU/1/20/1528/011 - 012 | Comirnaty Original/Omicron BA. 4-5 | Norway | 11.11.2022 |
| EU/1/20/1528/011-012 | Comirnaty Original/Omicron BA.4-5 | Iceland | 8.12.2022 |
| EU/1/20/1528/013 | Comirnaty | Norway | 22.12.2022 |
| EU/1/20/1528/014 | Comirnaty Original/Omicron BA. 4-5 | Norway | 22.12.2022 |
| EU/2/10/111/009-017 | Meloxoral | Iceland | 15.12.2022 |
| EU/2/10/111/009-017 | Meloxoral | Norway | 30.11.2022 |

EU-Number

Product

Country

Date of authorisation

EU/1/13/861/003-004

Procysbi

Iceland

23.8.2022

EU/1/13/861/003-004

Procysbi

Norway

17.8.2022

EU/1/15/1061

Genvoya

Norway

3.10.2022

EU/1/15/1061/003-004

Genvoya

Iceland

13.10.2022

EU/1/17/1217/004

Nitisinone MDK

Norway

16.8.2022

EU/1/17/1229

Dupixent

Norway

13.10.2022

EU/1/17/1229/021-022

Dupixent

Norway

16.8.2022

EU/1/18/1289/005-006

Biktavry

Norway

9.12.2022

EU/1/18/1289/005-006

Biktavry

Iceland

14.12.2022

EU/1/19/1361/004-005

Skyrizi

Norway

8.12.2022

EU/1/19/1404/010-011

Rinvoq

Iceland

16.8.2022

EU/1/19/1404/010-011

Rinvoq

Norway

16.8.2022

EU/1/20/1500/003

Xofluza

Iceland

6.9.2022

EU/1/20/1507/002-003

Spikevax

Norway

16.8.2022

EU/1/20/1507/004-005

Spikevax bivalent Original/Omicron BA.1

Norway

01.09.2022

EU/1/20/1507/002-003

Spikevax

Iceland

1.9.2022

EU/1/20/1507/006

Spikevax bivalent Original/Omicron BA.4-5

Norway

20.10.2022

EU/1/20/1507/007-008

Spikevax bivalent Original/Omicron BA.1

Norway

20.10.2022

EU/1/20/1507/009-010

Spikevax bivalent Original/Omicron BA.4-5

Norway

19.12.2022

EU/1/20/1528/006 -007

Comirnaty Original/Omicron BA.1

Norway

1.9.2022

EU/1/20/1528/008 -009

Comirnaty Original/Omicron BA. 4-5

Norway

12.9.2022

EU/1/20/1528/010

Comirnaty

Norway

20.10.2022

EU/1/20/1528/010

Comirnaty

Iceland

3.11.2022

EU/1/20/1528/011 - 012

Comirnaty Original/Omicron BA. 4-5

Norway

11.11.2022

EU/1/20/1528/011-012

Comirnaty Original/Omicron BA.4-5

Iceland

8.12.2022

EU/1/20/1528/013

Comirnaty

Norway

22.12.2022

EU/1/20/1528/014

Comirnaty Original/Omicron BA. 4-5

Norway

22.12.2022

EU/2/10/111/009-017

Meloxoral

Iceland

15.12.2022

EU/2/10/111/009-017

Meloxoral

Norway

30.11.2022

---

ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 July – 31 December 2022:

| EU-Number | Product | Country | Date of withdrawal |
| --- | --- | --- | --- |
| EU/1/00/166 | NeuroBloc | Liechtenstein | 31.12.2022 |
| EU/1/00/166 | NeuroBloc | Norway | 31.12.2022 |
| EU/1/01/174 | Starlix | Iceland | 17.8.2022 |
| EU/1/03/251 | Hepsera | Iceland | 12.12.2022 |
| EU/1/03/251 | Hepsera | Liechtenstein | 30.11.2022 |
| EU/1/03/251 | Hepsera | Norway | 12.12.2022 |
| EU/1/07/384 | Docetaxel Zentiva | Norway | 13.9.2022 |
| EU/1/07/421 | Glubrava | Iceland | 1.9.2022 |
| EU/1/08/498 | Thymanax | Iceland | 13.7.2022 |
| EU/1/08/498 | Thymanax | Liechtenstein | 31.7.2022 |
| EU/1/08/498 | Thymanax | Norway | 21.9.2022 |
| EU/1/10/616 | Temozolomide HEXAL | Liechtenstein | 30.9.2022 |
| EU/1/10/617 | Temozolomide Sandoz | Liechtenstein | 30.9.2022 |
| EU/1/10/617 | Temozolomide Sandoz | Norway | 27.10.2022 |
| EU/1/13/825 | Imatinib Actavis | Iceland | 1.9.2022 |
| EU/1/13/825 | Imatinib Actavis | Norway | 14.7.2022 |
| EU/1/15/1042 | Zalviso | Iceland | 17.8.2022 |
| EU/1/15/1042 | Zalviso | Liechtenstein | 31.8.2022 |
| EU/1/15/1042 | Zalviso | Norway | 13.9.2022 |
| EU/1/15/1069 | Episalvan | Norway | 21.9.2022 |
| EU/1/19/1359 | Trogarzo | Liechtenstein | 31.12.2022 |
| EU/1/19/1378 | Temybric Ellipta | Liechtenstein | 31.8.2022 |
| EU/1/19/1378 | Temybric Ellipta | Norway | 26.10.2022 |
| EU/1/19/1387 | Senstend | Iceland | 25.8.2022 |
| EU/1/19/1387 | Senstend | Norway | 21.9.2022 |
| EU/2/02/036 | Nobilis OR inac | Liechtenstein | 30.9.2022 |
| EU/2/02/036 | Nobilis OR inac | Norway | 14.10.2022 |
| EU/2/10/106 | Bovilis BTV8 | Liechtenstein | 31.8.2022 |
| EU/2/10/106 | Bovilis BTV8 | Norway | 14.9.2022 |
| EU/2/11/137 | Activyl Tick Plus | Liechtenstein | 30.9.2022 |
| EU/2/11/137 | Activyl Tick Plus | Norway | 25.10.2022 |

EU-Number

Product

Country

Date of withdrawal

EU/1/00/166

NeuroBloc

Liechtenstein

31.12.2022

EU/1/00/166

NeuroBloc

Norway

31.12.2022

EU/1/01/174

Starlix

Iceland

17.8.2022

EU/1/03/251

Hepsera

Iceland

12.12.2022

EU/1/03/251

Hepsera

Liechtenstein

30.11.2022

EU/1/03/251

Hepsera

Norway

12.12.2022

EU/1/07/384

Docetaxel Zentiva

Norway

13.9.2022

EU/1/07/421

Glubrava

Iceland

1.9.2022

EU/1/08/498

Thymanax

Iceland

13.7.2022

EU/1/08/498

Thymanax

Liechtenstein

31.7.2022

EU/1/08/498

Thymanax

Norway

21.9.2022

EU/1/10/616

Temozolomide HEXAL

Liechtenstein

30.9.2022

EU/1/10/617

Temozolomide Sandoz

Liechtenstein

30.9.2022

EU/1/10/617

Temozolomide Sandoz

Norway

27.10.2022

EU/1/13/825

Imatinib Actavis

Iceland

1.9.2022

EU/1/13/825

Imatinib Actavis

Norway

14.7.2022

EU/1/15/1042

Zalviso

Iceland

17.8.2022

EU/1/15/1042

Zalviso

Liechtenstein

31.8.2022

EU/1/15/1042

Zalviso

Norway

13.9.2022

EU/1/15/1069

Episalvan

Norway

21.9.2022

EU/1/19/1359

Trogarzo

Liechtenstein

31.12.2022

EU/1/19/1378

Temybric Ellipta

Liechtenstein

31.8.2022

EU/1/19/1378

Temybric Ellipta

Norway

26.10.2022

EU/1/19/1387

Senstend

Iceland

25.8.2022

EU/1/19/1387

Senstend

Norway

21.9.2022

EU/2/02/036

Nobilis OR inac

Liechtenstein

30.9.2022

EU/2/02/036

Nobilis OR inac

Norway

14.10.2022

EU/2/10/106

Bovilis BTV8

Liechtenstein

31.8.2022

EU/2/10/106

Bovilis BTV8

Norway

14.9.2022

EU/2/11/137

Activyl Tick Plus

Liechtenstein

30.9.2022

EU/2/11/137

Activyl Tick Plus

Norway

25.10.2022

---

ANNEX V

List of suspended marketing authorisations

The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 July – 31 December 2022:

| EU-Number | Product | Country | Date of suspension |
| --- | --- | --- | --- |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |

EU-Number

Product

Country

Date of suspension

---